|
2025 Journal Article Biomarkers in renal cell carcinoma: a systematic review and immunohistochemical validation studyBerezowski, Brett, Boothe, Robert, Chaplin, Billy, Del Vecchio, Sharon J., Fares, Zakariya, Humphries, Tyrone L. R., Ng, Keng Lim, Noonan, Taylor, Samaratunga, Hemamali, Urquhart, Aaron, Vesey, David A., Wood, Simon T., Gobe, Glenda C. and Ellis, Robert J. (2025). Biomarkers in renal cell carcinoma: a systematic review and immunohistochemical validation study. Cancers, 17 (15) 2588, 2588-15. doi: 10.3390/cancers17152588 |
|
2025 Journal Article Development and retrospective validation of an artificial intelligence system for diagnostic assessment of prostate biopsies: study protocolMulliqi, Nita, Blilie, Anders, Ji, Xiaoyi, Szolnoky, Kelvin, Olsson, Henrik, Titus, Matteo, Martinez Gonzalez, Geraldine, Boman, Sol Erika, Valkonen, Masi, Gudlaugsson, Einar, Kjosavik, Svein Reidar, Asenjo, José, Gambacorta, Marcello, Libretti, Paolo, Braun, Marcin, Kordek, Radzislaw, Łowicki, Roman, Hotakainen, Kristina, Väre, Päivi, Pedersen, Bodil Ginnerup, Sørensen, Karina Dalsgaard, Ulhøi, Benedicte Parm, Rantalainen, Mattias, Ruusuvuori, Pekka, Delahunt, Brett, Samaratunga, Hemamali, Tsuzuki, Toyonori, Janssen, Emilius Adrianus Maria, Egevad, Lars ... Eklund, Martin (2025). Development and retrospective validation of an artificial intelligence system for diagnostic assessment of prostate biopsies: study protocol. BMJ Open, 15 (7) e097591, e097591-7. doi: 10.1136/bmjopen-2024-097591 |
|
2025 Journal Article Intraductal carcinoma of the prostate is a marker of invasive diseaseDelahunt, Brett, Samaratunga, Hemamali and Egevad, Lars (2025). Intraductal carcinoma of the prostate is a marker of invasive disease. Pathology, 57 (6), 808-809. doi: 10.1016/j.pathol.2025.06.002 |
|
2025 Journal Article Physiological Zonal Anatomical Variation and Distribution of <scp>PSMA</scp> Activity Within the Prostate on <scp>PSMA</scp><scp>PET</scp>: A Study of 93 Prostatectomy Specimens Correlated to <scp>MRI</scp> and HistologyVasquez, Leon, Singh, Dalveer, Kreltszheim, Michael, Samaratunga, Hemamali, Drew, Zachary and Rothe, Chris (2025). Physiological Zonal Anatomical Variation and Distribution of PSMA Activity Within the Prostate on PSMAPET: A Study of 93 Prostatectomy Specimens Correlated to MRI and Histology. Journal of Medical Imaging and Radiation Oncology, 69 (4), 447-451. doi: 10.1111/1754-9485.13855 |
|
2025 Journal Article High proportion of clinically significant prostate adenocarcinomas in radical cystoprostatectomy specimens following complete prostate samplingDelahunt, Brett, Johannsen, Shulammite, Egevad, Lars, Yaxley, John W., Le Fevre, Ian K., Perry-Keene, Joanna L., Coughlin, Geoffrey and Samaratunga, Hemamali (2025). High proportion of clinically significant prostate adenocarcinomas in radical cystoprostatectomy specimens following complete prostate sampling. Pathology, 57 (6), 708-711. doi: 10.1016/j.pathol.2025.03.005 |
|
2025 Journal Article Gleason scores provide more accurate prognostic information than grade groupsEgevad, Lars, Micoli, Chiara, Delahunt, Brett, Samaratunga, Hemamali, Garmo, Hans, Stattin, Pär and Eklund, Martin (2025). Gleason scores provide more accurate prognostic information than grade groups. Pathology, 57 (3), 293-296. doi: 10.1016/j.pathol.2024.12.633 |
|
2025 Conference Publication Non-invasive detection of significant prostate cancer with a 3-gene urine testRoberts, Matthew, Koo, Kevin, Yaxley, John, Samaratunga, Hema, Jones, Andrew, Trau, Matt and Gardiner, Frank (2025). Non-invasive detection of significant prostate cancer with a 3-gene urine test. 77th Annual Scientific Meeting of the Urological-Society-of-Australia-and-New Zealand, Perth, WA Australia, 1-4 March 2025. Chichester, West Sussex, United Kingdom: Wiley. |
|
2024 Journal Article Benign prostatic hyperplasia and insignificant prostate cancer with very high levels of serum prostate specific antigenSamaratunga, Hemamali, Delahunt, Brett, Olsson, Mats, Aly, Markus, Egevad, Lars and Yaxley, John (2024). Benign prostatic hyperplasia and insignificant prostate cancer with very high levels of serum prostate specific antigen. Pathology, 56 (7), 1059-1061. doi: 10.1016/j.pathol.2024.05.013 |
|
2024 Journal Article Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristicsRoberts, Matthew J., Papa, Nathan, Veerman, Hans, de Bie, Katelijne, Morton, Andrew, Franklin, Anthony, Raveenthiran, Sheliyan, Yaxley, William J., Donswijk, Maarten L., van der Poel, Henk G., Samaratunga, Hemamali, Wong, David, Brown, Nicholas, Parkinson, Robert, Gianduzzo, Troy, Kua, Boon, Coughlin, Geoffrey D., Oprea‐Lager, Daniela E., Emmett, Louise, van Leeuwen, Pim J., Yaxley, John W. and Vis, André N. (2024). Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics. BJU International, 134 (S2), 47-55. doi: 10.1111/bju.16482 |
|
2024 Journal Article Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancerMartini, Carmela, Logan, Jessica M., Sorvina, Alexandra, Prabhakaran, Sarita, Ung, Benjamin S Y., Johnson, Ian R. D., Hickey, Shane M., Brooks, Robert D., Caruso, Maria C., Klebe, Sonja, Karageorgos, Litsa, O’Leary, John J., Delahunt, Brett, Samaratunga, Hemamali and Brooks, Douglas A (2024). Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer. Virchows Archiv, 485 (4), 723-728. doi: 10.1007/s00428-023-03643-1 |
|
2024 Journal Article Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkersLogan, Jessica M., Martini, Carmela, Sorvina, Alexandra, Johnson, Ian R. D., Brooks, Robert D., Caruso, Maria C., Huzzell, Chelsea, Moore, Courtney R., Karageorgos, Litsa, Butler, Lisa M., Tewari, Prerna, Prabhakaran, Sarita, Hickey, Shane M., Klebe, Sonja, Samaratunga, Hemamali, Delahunt, Brett, Moretti, Kim, O’Leary, John J., Brooks, Douglas A. and Ung, Ben S.-Y. (2024). Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkers. Scientific Data, 11 (1) 852, 852. doi: 10.1038/s41597-024-03696-0 |
|
2024 Journal Article Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based studyEgevad, Lars, Micoli, Chiara, Delahunt, Brett, Samaratunga, Hemamali, Orrason, Andri Wilberg, Garmo, Hans, Stattin, Pär and Eklund, Martin (2024). Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study. Virchows Archiv, 484 (6), 995-1003. doi: 10.1007/s00428-024-03810-y |
|
2024 Journal Article Prognosis of Gleason score 9–10 prostatic adenocarcinoma in needle biopsies: a nationwide population-based studyEgevad, Lars, Micoli, Chiara, Samaratunga, Hemamali, Delahunt, Brett, Garmo, Hans, Stattin, Pär and Eklund, Martin (2024). Prognosis of Gleason score 9–10 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study. European Urology Oncology, 7 (2), 213-221. doi: 10.1016/j.euo.2023.11.002 |
|
2024 Journal Article UrethroNAV: the aetiology and extent of idiopathic urethral stricture in an Australian populationDesai, Devang, Harrison, William, Raveenthiran, Sheliyan, Samaratunga, Hemamali and De Win, Gunter (2024). UrethroNAV: the aetiology and extent of idiopathic urethral stricture in an Australian population. Translational Andrology and Urology, 13 (3), 423-432. doi: 10.21037/tau-23-549 |
|
2024 Conference Publication Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emissionVis, A., Meijer, D., Roberts, M.J., Siriwardana, A.R., Morton, A., Yaxley, J.W., Samaratunga, H., Emmett, L., Van Der Ven, P.M., Heymans, M.W., Nieuwenhuijzen, J.A., Van Der Poel, H.G., Van Donswijk, M.L., Boellaard, T.N., Schoots, I.G., Stricker, P., Haynes, A-M., Oprea-Lager, D.E., Coughlin, G.D. and Van Leeuwen, P.J. (2024). Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission. EAU24 - 39th Annual EAU Congress, Paris, France, 5-8 April 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(24)00422-6 |
|
2024 Journal Article Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patientsSamaratunga, Hemamali, Egevad, Lars, Yaxley, John, Perry-Keene, Joanna, Le Fevre, Ian, Kench, James, Matsika, Admire, Bostwick, David, Iczkowski, Kenneth and Delahunt, Brett (2024). Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patients. Pathology, 56 (1), 33-38. doi: 10.1016/j.pathol.2023.10.005 |
|
2023 Journal Article Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomographyVis, André N., Meijer, Dennie, Roberts, Matthew J., Siriwardana, Amila R., Morton, Andrew, Yaxley, John W., Samaratunga, Hemamali, Emmett, Louise, van de Ven, Peter M., Heymans, Martijn W., Nieuwenhuijzen, Jakko A., van der Poel, Henk G., Donswijk, Maarten L., Boellaard, Thierry N., Schoots, Ivo G., Stricker, Phillip, Haynes, Anne-Maree, Oprea-Lager, Daniela E., Coughlin, Geoffrey D. and van Leeuwen, Pim J. (2023). Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomography. European Urology Oncology, 6 (6), 553-563. doi: 10.1016/j.euo.2023.03.010 |
|
2023 Journal Article Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spreadSorvina, Alexandra, Martini, Carmela, Prabhakaran, Sarita, Logan, Jessica M., S-Y. Ung, Benjamin, Moore, Courtney, Johnson, Ian R.D., Lazniewska, Joanna, Tewari, Prerna, Malone, Victoria, Brooks, Robert D., Hickey, Shane M., Caruso, Maria C., Klebe, Sonja, Karageorgos, Litsa, O’Leary, John J., Delahunt, Brett, Samaratunga, Hemamali and Brooks, Doug A. (2023). Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread. Pathology, 55 (6), 792-799. doi: 10.1016/j.pathol.2023.05.004 |
|
2023 Journal Article Web-grading—a tool to test personal grading of renal and prostate cancerKristiansen, Glen, Schmid, Matthias, Egevad, Lars, Samaratunga, Hemamali, Varma, Murali, Inam, Kaan, Thiesen, Hans-Jürgen, Delahunt, Brett and Dai, Yulin (2023). Web-grading—a tool to test personal grading of renal and prostate cancer. APMIS, 131 (10), 528-535. doi: 10.1111/apm.13347 |
|
2023 Journal Article Publisher Correction to: Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancerMartini, Carmela, Logan, Jessica M., Sorvina, Alexandra, Prabhakaran, Sarita, Ung, Benjamin S-Y., Johnson, Ian R. D., Hickey, Shane M., Brooks, Robert D., Caruso, Maria C., Klebe, Sonja, Karageorgos, Litsa, O’Leary, John J., Delahunt, Brett, Samaratunga, Hemamali, Brooks, Douglas A. and kConFab Consortium (2023). Publisher Correction to: Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer. Virchows Archiv, 487 (1), 1-1. doi: 10.1007/s00428-023-03666-8 |
